Table 3.
Cytogenetic Response Within Risk Groups in Different CML Trials
Study (Reference)
.
% Cytogenetic Response in Risk Group
.
Good
.
Intermediate
.
Poor
.
MDACC (2)
72
59
39
MRC (12)
34
31
7
Study (Reference)
.
% Cytogenetic Response in Risk Group
.
Good
.
Intermediate
.
Poor
.
MDACC (2)
72
59
39
MRC (12)
34
31
7
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal